Induction of Mitogen-Activated Protein Kinases Is Proportional to the Amount of Pressure Overload
暂无分享,去创建一个
Cinzia Perrino | Raffaele Izzo | Anna Sannino | Massimo Chiariello | Giovanni Esposito | M. Chiariello | A. Sannino | Gianluigi Pironti | G. Esposito | G. Gargiulo | A. Franzone | R. Izzo | C. Perrino | Anna Franzone | E. di Pietro | Giuseppe Gargiulo | Gianluigi Pironti | A. Cannavo | G. Schiattarella | Gabriele Giacomo Schiattarella | Lorena Belardo | Elisa di Pietro | Giuliana Capretti | Alessandro Cannavo | G. Capretti | Giuliana Capretti | L. Belardo
[1] G. Esposito,et al. Cardiac hypertrophy: role of G protein-coupled receptors. , 2002, Journal of cardiac failure.
[2] J. Ross,et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[3] A. Böyum,et al. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[4] P. Insel,et al. Peripheral adrenergic receptors in hypertension. , 1990, Hypertension.
[5] J Ross,et al. Molecular and physiological alterations in murine ventricular dysfunction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[6] C. Indolfi,et al. Transient and reversible deoxyribonucleic acid damage in human left ventricle under controlled ischemia and reperfusion. , 2004, Journal of the American College of Cardiology.
[7] M. Chiariello,et al. Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure. , 2006, Vascular pharmacology.
[8] References , 1971 .
[9] W. Koch,et al. Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress , 2002, Circulation.
[10] M. Marber,et al. Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. , 2007, Pharmacology & therapeutics.
[11] R. Feldman. Insulin‐mediated sensitization of adenylyl cyclase activation , 1993, British journal of pharmacology.
[12] Marc A Pfeffer,et al. Controversies in ventricular remodelling , 2006, The Lancet.
[13] Hyung-Suk Kim,et al. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. , 2006, The Journal of clinical investigation.
[14] H. Rockman,et al. JNK1 is required to preserve cardiac function in the early response to pressure overload. , 2006, Biochemical and biophysical research communications.
[15] W. Koch,et al. Cardiac Overexpression of a Gq Inhibitor Blocks Induction of Extracellular Signal–Regulated Kinase and c-Jun NH2-Terminal Kinase Activity in In Vivo Pressure Overload , 2001, Circulation.
[16] K. Chien,et al. Transcriptional regulation during cardiac growth and development. , 1993, Annual review of physiology.
[17] G. Dorn,et al. Genetic Factors in Cardiac Hypertrophy , 2004, Annals of the New York Academy of Sciences.
[18] W. Ganong,et al. Extra-atrial expression of the gene for atrial natriuretic factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[19] C. Der,et al. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.
[20] C. Rackley,et al. Measurement of Left Ventricular Wall Thickness and Mass by Echocardiography , 1972, Circulation.